MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) for the quarter ended on June 30 2024 and for draft Annual Report for the FY 2023-24